GlassScriptPhysician profile
Anant Parikh
NPI 1174819148
$2,775.22
in general payments reported to CMS, 2019-2025
20 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $327 · 2021: $175 · 2022: $450 · 2023: $640 · 2024: $701 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,297.01 | 2022-2025 | Intellis Adaptivestim, Vectris Surescan, Inceptiv |
| Collegium Pharmaceutical, INC. | $255.11 | 2019-2023 | Xtampza, Belbuca |
| Pfizer INC. | $214.19 | 2019 | |
| Medtronic USA, INC. | $170.41 | 2019-2020 | |
| Painteq LLC | $158.12 | 2022 | |
| Mml US, INC. | $151.09 | 2024 | Reactiv8 |
| Nevro Corp. | $122.10 | 2020 | |
| Vertos Medical, INC. | $87.61 | 2021-2022 | |
| Novus Surgical Consultants | $62.94 | 2024 | |
| Stryker Corporation | $53.64 | 2024 | Optablate, Spinejack |
| Averitas Pharma INC. | $41.94 | 2023-2025 | Qutenza |
| Tersera Therapeutics LLC | $37.47 | 2024 | Prialt |
| Amgen INC. | $20.71 | 2020 | |
| Biogen, INC. | $19.92 | 2023 | Spinraza |
| Almatica Pharma LLC | $18.77 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $15.16 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.37 | 2019 | |
| Assertio Therapeutics, INC. | $12.08 | 2020 | |
| Vertiflex, INC. | $11.49 | 2019 | |
| Grt US Holding, INC. | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anant Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.